Arbutus Biopharma
ABUS
#6443
Rank
HK$6.08 B
Marketcap
HK$31.66
Share price
-13.62%
Change (1 day)
26.69%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): -HK$2.02

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is -HK$2.03. In 2024 the company made an earnings per share (EPS) of -HK$2.96 an increase over its 2023 EPS that were of -HK$3.43.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$2.02-31.77%
2024-HK$2.96-13.64%
2023-HK$3.43-4.35%
2022-HK$3.59-44.58%
2021-HK$6.47-17%
2020-HK$7.80-65.4%
2019-HK$22.53138.84%
2018-HK$9.43-22.44%
2017-HK$12.16-78.45%
2016-HK$56.45424.64%
2015-HK$10.76-20.19%
2014-HK$13.4887.96%
2013-HK$7.17-142.59%
2012HK$16.84-342.7%
2011-HK$6.94-25.82%
2010-HK$9.3547.8%
2009-HK$6.33-43.55%
2008-HK$11.21158.91%
2007-HK$4.33-111.88%
2006HK$36.46-552.53%
2005-HK$8.06-71.77%
2004-HK$28.54-14.48%
2003-HK$33.37-8.95%
2002-HK$36.6570.07%
2001-HK$21.5548.01%
2000-HK$14.56-38.54%
1999-HK$23.69-24.6%
1998-HK$31.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
NRC Health
NRC
HK$5.46-369.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-HK$0.47-76.92% Bahamas